Question 1

How many shares of OCUL does NewEdge Advisors, LLC own?

Accepted Answer

As of 2026-Q2, NewEdge Advisors, LLC holds 16,725 shares of OCUL (OCULAR THERAPEUTIX INC).

Question 2

What is NewEdge Advisors, LLC's OCUL position worth?

Accepted Answer

As of 2026-Q2, NewEdge Advisors, LLC's OCUL position is worth $164,240.

Question 3

Is NewEdge Advisors, LLC buying or selling OCUL?

Accepted Answer

In 2026-Q2, NewEdge Advisors, LLC increased their OCUL position (+21.7% change in shares).

Question 4

When did NewEdge Advisors, LLC first buy OCUL?

Accepted Answer

Based on available 13F filings, NewEdge Advisors, LLC first reported a position in OCUL in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	16,725	+21.7%	$164,240	0.0%	$9.82	27
2026-Q1	Increased	13,746	+1274.6%	$116,429	0.0%	$10.76	35
2025-Q4	Unchanged	1,000	0.0%	$12,140	0.0%	$12.20	0
2025-Q3	Decreased	1,000	-32.4%	$11,690	0.0%	$12.53	0
2025-Q2	Unchanged	1,480	0.0%	$13,734	0.0%	$9.22	0
2025-Q1	Unchanged	1,480	0.0%	$10,848	0.0%	$7.58	0
2024-Q4	Unchanged	1,480	0.0%	$12,639	0.0%	$8.35	0
2024-Q3	Unchanged	1,480	0.0%	$12,876	0.0%	$8.68	0